Report cover image

China Biotechnology Market Summary, Competitive Analysis and Forecast to 2028

Publisher MarketLine
Published Feb 23, 2024
Length 46 Pages
SKU # MTLN18746532

Description

China Biotechnology Market Summary, Competitive Analysis and Forecast to 2028


Summary

Biotechnology in China industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights
  • The biotechnology market encompasses a broad range of technologies, products, and services that utilize biological systems, organisms, or derivatives to develop or modify processes or products for specific applications.
  • The Chinese biotechnology market recorded revenues of $63.4 billion in 2023, representing a compound annual growth rate (CAGR) of 10.4% between 2018 and 2023.
  • The medical/healthcare segment accounted for the market's largest proportion in 2023, with total revenues of $34.9 billion, equivalent to 55.1% of the market's overall value.
  • The Chinese biotechnology market is experiencing growth due to innovation and potential therapeutic developments. China’s biotechnology market places a strong emphasis on research and development, and numerous businesses make large investments in this field. For instance, in August 2023, China introduced new attempts to attract foreign investors, promising to boost R&D in the biotech industry and fast-track cross-border data flows.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in China
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in China
  • Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the China biotechnology market with five year forecasts
Reasons to Buy
  • What was the size of the China biotechnology market by value in 2023?
  • What will be the size of the China biotechnology market in 2028?
  • What factors are affecting the strength of competition in the China biotechnology market?
  • How has the market performed over the last five years?
  • Who are the top competitors in China's biotechnology market?

Table of Contents

46 Pages
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Category segmentation
4.2. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What strategies do the leading players follow?
7.3. What is the rationale behind recent M&A activity?
8 Company Profiles
8.1. BeiGene Ltd
8.2. Shanghai Kehua Bio-engineering Co Ltd
8.3. Sinovac Biotech Ltd.
8.4. Novo Nordisk A/S
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: China biotechnology industry value: $ million, 2018-23
Table 2: China biotechnology industry category segmentation: % share, by value, 2018-2023
Table 3: China biotechnology industry category segmentation: $ million, 2018-2023
Table 4: China biotechnology industry geography segmentation: $ million, 2023
Table 5: China biotechnology industry value forecast: $ million, 2023-28
Table 6: BeiGene Ltd: key facts
Table 7: BeiGene Ltd: Annual Financial Ratios
Table 8: BeiGene Ltd: Key Employees
Table 9: BeiGene Ltd: Key Employees Continued
Table 10: BeiGene Ltd: Key Employees Continued
Table 11: Shanghai Kehua Bio-engineering Co Ltd: key facts
Table 12: Shanghai Kehua Bio-engineering Co Ltd: Annual Financial Ratios
Table 13: Shanghai Kehua Bio-engineering Co Ltd: Key Employees
Table 14: Sinovac Biotech Ltd.: key facts
Table 15: Sinovac Biotech Ltd.: Annual Financial Ratios
Table 16: Sinovac Biotech Ltd.: Key Employees
Table 17: Novo Nordisk A/S: key facts
Table 18: Novo Nordisk A/S: Annual Financial Ratios
Table 19: Novo Nordisk A/S: Key Employees
Table 20: Novo Nordisk A/S: Key Employees Continued
Table 21: China size of population (million), 2019-23
Table 22: China gdp (constant 2005 prices, $ billion), 2019-23
Table 23: China gdp (current prices, $ billion), 2019-23
Table 24: China inflation, 2019-23
Table 25: China consumer price index (absolute), 2019-23
Table 26: China exchange rate, 2019-23
List of Figures
Figure 1: China biotechnology industry value: $ million, 2018-23
Figure 2: China biotechnology industry category segmentation: $ million, 2018-2023
Figure 3: China biotechnology industry geography segmentation: % share, by value, 2023
Figure 4: China biotechnology industry value forecast: $ million, 2023-28
Figure 5: Forces driving competition in the biotechnology industry in China, 2023
Figure 6: Drivers of buyer power in the biotechnology industry in China, 2023
Figure 7: Drivers of supplier power in the biotechnology industry in China, 2023
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in China, 2023
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in China, 2023
Figure 10: Drivers of degree of rivalry in the biotechnology industry in China, 2023

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us